[DOI] [PMC free article] [PubMed] [Google Scholar] 18.Ali A., Lima Sampaio T., Khan H., Jeandet P., Kupeli Akkol E., Bahadar H., Costa Martins A.M
FOXO4-DRI has potential as a tumor suppressor due to its ability to target and eliminate senescent cells, which are often associated with a pro-inflammatory environment that can promote tumor growth
Available at personalcarecouncil.org
Composition GHK-Cu: 50 mg KPV: 10 mg BPC-157: 10 mg TB-500 (Thymosin Beta 4): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined evaluation of copper peptide, KPV tripeptide, BPC-157, and TB-500 in in-vitro or ex-vivo assay systems Assay development, including chromatographic separation of four co-formulated peptides Stability characterization of a four-analyte lyophilized blend under laboratory storage conditions Method documentation for HPLC/LC-MS identity and purity assessments Documentation COA pending third-party verification in progress Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease
(2) changes in the serum levels of ALT and aspartate transaminase (AST)
Reconstitution Calculator Use our reconstitution concentration calculator to determine your solution concentration (mcg/mL) based on peptide mass and diluent volume
.png?sfvrsn=f94c669f_5)
